Timolol maleate 0.5% or 0.1% gel-forming solution for infantile hemangiomas: A retrospective, multicenter, cohort study

Pediatric Dermatology

Volumn 29, Issue 1, 2012, Pages 28-31

  Chakkittakandiyil, Ajith ^a   Phillips, Rod ^b   Frieden, Ilona J ^c   Siegfried, Elaine ^d   Lara Corrales, Irene ^a   Lam, Joseph ^e   Bergmann, James ^e   Bekhor, Philip ^b   Poorsattar, Solmaz ^c   Pope, Elena ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SSM Cardinal Glennon Children's Medical Center   (United States)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TIMOLOL MALEATE;

ARTICLE; CAPILLARY HEMANGIOMA; CHILD; COHORT ANALYSIS; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SKIN BURNING SENSATION; SKIN DISEASE; SKIN IRRITATION; SKIN STINGING; SLEEP DISORDER; TREATMENT DURATION; TREATMENT RESPONSE;

ADMINISTRATION, TOPICAL; ADRENERGIC BETA-ANTAGONISTS; COHORT STUDIES; FEMALE; GELS; HEMANGIOMA; HUMANS; INFANT; MALE; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; SOLUTIONS; TIMOLOL; TREATMENT OUTCOME;

EID: 84856201139     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2011.01664.x     Document Type: Article

References (16)

1. Drolet BA, Esterly NB, Frieden IJ,. Hemangiomas in children. N Eng J Med 1999; 341: 173-181. (Pubitemid 29325746)
2. Léauté-Labrze C, Dumas de la Roque E, Hubiche T, et al., Propranolol for severe hemangiomas of infancy. N Engl J Med 2008; 358: 2649-2651. (Pubitemid 351831393)
3. Sans V, de la Roque ED, Berge J, et al., Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics 2009; 124: e423-e431.
4. Maguiness SM, Frieden IJ,. Current management of infantile hemangiomas. Semin Cutan Med Surg 2010; 29: 106-114.
5. Ho NT, Lansang P, Pope E,. Topical imiquimod in the treatment of infantile hemangiomas: a retrospective study. J Am Acad Dermatol 2007; 56: 63-68. (Pubitemid 46016997)
6. Pope E, Chakkittakandiyil A,. Topical timolol gel for infantile hemangiomas: a pilot study. Arch Dermatol 2010; 146: 564-565.
7. Guo S, Ni N,. Topical treatment for capillary hemangioma of the eyelid using beta-blocker solution. Arch Ophthalmol 2010; 128: 255-256.
8. Khunger N, Pahwa M,. Dramatic response of a large hemifacial infantile hemangioma associated with PHACE syndrome to topical timolol lotion. Br J Dermatol 2011; 164: 886-888.
9. Pope E, Krafchik BR, Macarthur C, et al., Oral versus high-dose pulse corticosteroids for problematic infantile hemangiomas: a randomized, controlled trial. Pediatrics 2007; 119: e1239-e1247. (Pubitemid 46871240)
10. Zimmermann AP, Wiegand S, Werner JA, et al., Propranolol therapy for infantile haemangiomas: review of the literature. Int J Pediatr Otorhinolaryngol 2010; 74: 338-342.
11. Storch CH, Hoeger PH,. Propranolol for infantile hemangiomas: insights into molecular mechanisms of action. Br J Dermatol 2010; 163: 269-274.
12. Singh BN, Williams FM, Whitlock RM, et al., Plasma timolol levels and systolic time intervals. Clin Pharmacol Ther 1980; 28: 159-166. (Pubitemid 10024868)
13. Burnstine RA, Felton JL, Ginther WH,. Cardiorespiratory reaction to timolol maleate in a pediatric patient: a case report. Ann Ophthalmol 1982; 14: 905-906. (Pubitemid 12002462)
14. Korte JM, Kaila T, Saari KM,. Systemic bioavailability and cardiopulmonary effects of 0.5% timolol eyedrops. Graefes Arch Clin Exp Ophthalmol 2002; 240: 430-435. (Pubitemid 36097063)
15. Shedden AH, Laurence J, Barrish A, et al., Plasma timolol concentrations of timolol maleate: timolol gel-forming solution (TIMOPTIC-XE) once daily versus timolol maleate ophthalmic solution twice daily. Doc Ophthalmol 2001; 103: 73-79. (Pubitemid 32926916)
16. Ahmed AI, van Mierlo P, Jansen P,. Sleep disorders, nightmares, depression and anxiety in an elderly patient treated with low-dose metoprolol. Gen Hosp Psychiatry 2010; 32: 646.